Education

Ph.D. in Pharmacy, Department of Pharmacy and Pharmaceutical Technology, University of Valencia, Spain, 1989

Current position

Professor, Department of Pharmacy and Pharmaceutical Technology, University of Valencia, Burjassot, Spain

Publications (since 2009)

1. Castangia, I., Manca, M. L., Caddeo, C., Maxia, A., Murgia, S., Pons, R., Demurtas, D., Pando, D., Falconieri, D., Peris, J. E., Fadda, A. M. and Manconi, M. (2015). Faceted phospholipid vesicles tailored for the delivery of Santolina insularis essential oil to the skin. Colloids Surf B Biointerfaces 132: 185-193.
   
2. Miguel-Lillo, B., Valenzuela, B., Peris-Ribera, J. E., Soto-Matos, A. and Pérez-Ruixo, J. J. (2015). Population pharmacokinetics of kahalalide F in advanced cancer patients. Cancer Chemother Pharmacol 76(2): 365-374.
   
3. Usach, I., Taléns-Visconti, R., Magraner-Pardo, L. and Peris, J. E. (2015). Hesperetin induces melanin production in adult human epidermal melanocytes. Food Chem Toxicol 80: 80-84.
   
4. Usach, I., Melis, V., Gandía, P. and Peris, J. E. (2014). Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline. Antimicrob Agents Chemother 58(12): 7041-7048.
   
5. Pérez-Ruixo, C., Peris, J. E., Escudero-Ortiz, V., Bretcha-Boix, P., Farré-Alegre, J., Pérez-Ruixo, J. J. and Valenzuela, B. (2014). Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients. Cancer Chemother Pharmacol 73(5): 1009-1020.
   
6. Orden, S., De Pablo, C., Rios-Navarro, C., Martinez-Cuesta, M. A., Peris, J. E., Barrachina, M. D., Esplugues, J. V. and Alvarez, A. (2014). Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95. J Antimicrob Chemother 69(4): 995-1004.
   
7. Melis, V., Usach, I., Peris, J. E. (2014). High-performance liquid chromatography for the analysis of non-nucleoside reverse transcriptase inhibitors in biological fluids and pharmaceutical products. In: Zuo, Y.(ed). High-Performance Liquid Chromatography (HPLC): Principles, Practices and Procedures.Nova Science Publishers: 67-86.
   
8. Zhao, W., Kaguelidou, F., Biran, V., Zhang, D., Allegaert, K., Capparelli, E. V., Holford, N., Kimura, T., Lo, Y. L., Peris, J. E., Thomson, A., van den Anker, J. N., Fakhoury, M. and Jacqz-Aigrain, E. (2013). External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings. Br J Clin Pharmacol 75(4): 1068-1080.
   
9. Perez-Ruixo, C., Valenzuela, B., Peris, J. E., Bretcha-Boix, P., Escudero-Ortiz, V., Farré-Alegre, J. and Pérez-Ruixo, J. J. (2013). Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery. Cancer Chemother Pharmacol 71(3): 693-704.
   
10. Hernández-Mijares, A., Banuls, C., Peris, J. E., Monzo, N., Jover, A., Bellod, L., Victor, V. M. and Rocha, M. (2013). A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects. Food Chem 141(2): 1267-1272.
    
11. Pérez-Ruixo, C., Valenzuela, B., Peris, J. E., Bretcha-Boix, P., Escudero-Ortiz, V., Farré-Alegre, J. and Pérez-Ruixo, J. J. (2013). Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin. Clin Pharmacokinet 52(12): 1111-1125.
    
12. Usach, I., Melis, V. and Peris, J. E. (2013). Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability. J Int AIDS Soc 16: 1-14.
    
13. De Pablo, C., Orden, S., Peris, J. E., Barrachina, M. D., Esplugues, J. V. and Alvarez, A. (2013). Profile of leukocyte-endothelial cell interactions induced in venules and arterioles by nucleoside reverse-transcriptase inhibitors in vivo. J Infect Dis 208(9): 1448-1453.
    
14. Usach, I., Melis, V., Peris, J. E. (2013). Vancomycin: Use, Dosing and Therapeutic Drug Monitoring (2013). In: Gafar, A.(ed). Vancomycin: Biosynthesis, Clinical Uses and Adverse Effects.Nova Science Publishers: 55-80.
    
15. Melis, V., Usach, I. and Peris, J. E. (2012). Determination of sertraline in rat plasma by HPLC and fluorescence detection and its application to in vivo pharmacokinetic studies. J Sep Sci 35(23): 3302-3307.
    
16. Ubeda, A., Ferrandiz, L., Maicas, N., Gomez, C., Bonet, M. and Peris, J. E. (2012). Potentially inappropriate prescribing in institutionalised older patients in Spain: the STOPP-START criteria compared with the Beers criteria. Pharm Pract (Granada) 10(2): 83-91.
    
17. Usach, I. and Peris, J. E. (2011). Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum. Int J Pharm 419(1-2): 186-191.
    
18. Marqués-Miñana, M. R., Saadeddin, A. and Peris, J. E. (2010). Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline. Br J Clin Pharmacol 70(5): 713-720.
    
19. Almudever, P., Peris, J. E., Garrigues, T., Diez, O., Melero, A. and Alós, M. (2010). Quantification of nortriptyline in plasma by HPLC and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 878(9-10): 841-844.
    
20. Araico, A., Saadeddin, A., Torres-Molina, F. and Peris, J. E. (2009). In vivo evaluation of a new sustained-release formulation of morphine. Pharmazie 64(10): 653-655.
    
21. Saadeddin, A. and Peris, J. E. (2009). Pharmacokinetic interaction between efavirenz and ketoconazole in rats. Xenobiotica 39(2): 135-139.
    
22. Ochiuz, L. and Peris, J. E. (2009). Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique. Med Chem 5(2): 191-196.